SEP 02, 2021 8:00 AM PDT

Will an Extra COVID Vaccine Shot Benefit People With Autoimmune Conditions?

WRITTEN BY: Tara Fernandez

The global rollout of COVID-19 vaccines has helped save countless lives during the pandemic. Studies have shown that vaccinated individuals have a markedly reduced risk of experiencing severe COVID-19 symptoms, hospitalization, and death. In addition, fully vaccinated individuals are less likely to transmit the coronavirus to others.

However, vaccines don’t work equally for everyone in the community. For example, COVID-19 vaccines aren’t as effective for patients with autoimmune diseases, particularly those taking immunosuppressive medications to treat their conditions. Autoimmune diseases arise from abnormal immune responses that target the body’s healthy tissues, with a complex network of genetic and environmental factors said to trigger these conditions.

The National Institutes of Health has launched a new clinical trial, the COVID‐19 Booster Vaccine in Autoimmune Disease Non‐Responders Study, to develop better strategies for protecting people with autoimmune disorders during the pandemic. 

The trial’s 600 participants will include those diagnosed with the autoimmune conditions multiple sclerosis, pemphigus, rheumatoid arthritis, systemic lupus erythematosus, or systemic sclerosis. These conditions have been selected as immunosuppressive drugs used to treat them have been linked to poor antibody responses after receiving vaccines.  

Researchers are interested in whether an extra dose of a COVID-19 vaccine will help boost antibody responses and better protect patients from SARS-CoV-2 infections. In addition, the study will investigate whether a brief pause in participants’ immunosuppressive therapy regime around the time they receive the third ‘booster’ vaccine dose will help improve immune responses further. 

With around 8 percent of people in the U.S. living with autoimmune diseases and significantly higher rates of COVID-19 deaths among this patient population, the results of the trial will help shape more effective, life-saving vaccination strategies for many. 

 


Sources: National Institutes of Health, ClinicalTrials.gov.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 12, 2021
Health & Medicine
Why Autoimmune Diseases Strike Women More Often Than Men
AUG 12, 2021
Why Autoimmune Diseases Strike Women More Often Than Men
According to a 2020 study published in Cureus, autoimmune diseases are two times more prevalent in women than men, with ...
AUG 18, 2021
Health & Medicine
Brain-Gut Connection in Brain Disorders Potentially Explained
AUG 18, 2021
Brain-Gut Connection in Brain Disorders Potentially Explained
Gut microbes are believed to influence brain disorders, potentially through the vagus nerve, as seen in experimental and ...
SEP 14, 2021
Immunology
The Spleen Creates Long-Lasting Protection Against the Flu Virus
SEP 14, 2021
The Spleen Creates Long-Lasting Protection Against the Flu Virus
You share an elevator with an individual who is coughing and sneezing, only to find yourself feeling unwell a few days l ...
SEP 23, 2021
Immunology
Houses on Mars Held Together With Astronaut Blood?!
SEP 23, 2021
Houses on Mars Held Together With Astronaut Blood?!
A protein abundantly present in the blood plasma of astronauts is perfect for building shelters in outer space, say rese ...
OCT 19, 2021
Immunology
Reverse Vaccinations Tame the Immune System to Help Hemophilia Patients
OCT 19, 2021
Reverse Vaccinations Tame the Immune System to Help Hemophilia Patients
In patients with hemophilia A—a hereditary disorder where the blood cannot clot properly—their immune system ...
OCT 19, 2021
Drug Discovery & Development
Researchers develop a potent antiviral drug for dengue fever
OCT 19, 2021
Researchers develop a potent antiviral drug for dengue fever
Dengue fever is a mosquito borne illness that is widespread, especially in tropical countries. The global incidence of d ...
Loading Comments...